Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity.
Plasmablastic lymphoma is an aggressive subtype of diffuse large B-cell lymphoma that is mainly observed in patients with the human immunodeficiency virus (HIV) infection, and it tends to arise in the oral cavity. We present a case of an HIV-infected patient with plasmablastic lymphoma with prolonged survival. The 30-yr-old woman was found to have an oral lesion at the time of the diagnosis of HIV infection. Histological and immunochemical examination of biopsy of the oral lesion showed plasmablastic lymphoma (CD138+). She received two cycles of cyclophosphamide, vincristine, doxorubicin, and prednisolone (CHOP) that started 10 weeks after the initiation of antiretroviral therapy. The continuing pancytopenia and an adenoviral febrile infection did not permit further antineoplastic treatment. A gradual decrease of the oral lesion was noted after the second cycle of chemotherapy that led to the disappearance of the lesion 7 months later. The patient remains in complete remission 61 months after the diagnosis of plasmablastic lymphoma.
Panos
George
G
HIV Unit, 2nd Internal Medicine Clinic, 1st IKA Hospital, Athens, Greece.
Karveli
Efthymia A
EA
Nikolatou
Ourania
O
Falagas
Matthew E
ME
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology / Q000473:pathology* / Q000821:virology; D000328:Adult; D005260:Female; D006678:HIV / Q000502:physiology; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000209:etiology* / Q000473:pathology*; D009055:Mouth / Q000473:pathology*; D016019:Survival Analysis; D013997:Time Factors